Virpax Pharmaceuticals In... (VRPX)
0.35
0.00 (0.29%)
At close: Jan 15, 2025, 3:59 PM
0.34
-2.06%
After-hours Jan 15, 2025, 07:54 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Net Income | -15.19M | -21.65M | -12.06M | -4.34M | -3.31M | -2.64M |
| Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a |
| Stock-Based Compensation | 544.77K | 745.03K | 974.23K | 1.47M | 678.15K | 384.95K |
| Other Working Capital | 4.19M | 4.05M | -2.71M | -13.09K | 7.95K | -13.13K |
| Other Non-Cash Items | 599.43K | 745.03K | -61.82K | 153.22K | 564.64K | 14.98K |
| Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a |
| Change in Working Capital | 4.19M | 3.06M | -3.40M | 1.33M | 931.89K | 441.37K |
| Operating Cash Flow | -9.85M | -17.85M | -14.54M | -1.38M | -1.13M | -1.80M |
| Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a |
| Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a |
| Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a |
| Debt Repayment | n/a | n/a | -1.50M | 72.10K | 500.00K | 554.77K |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | n/a | n/a | -5.19M | -50.88K | 625.00K | n/a |
| Financial Cash Flow | n/a | n/a | 51.33M | 1.40M | 1.13M | 1.67M |
| Net Cash Flow | -9.85M | -17.85M | 36.79M | 13.26K | -6.83K | -124.87K |
| Free Cash Flow | -9.85M | -17.85M | -14.54M | -1.38M | -1.13M | -1.80M |